HYDROXYPROGESTERONE CAPROATE Drug Patent Profile
✉ Email this page to a colleague
When do Hydroxyprogesterone Caproate patents expire, and when can generic versions of Hydroxyprogesterone Caproate launch?
Hydroxyprogesterone Caproate is a drug marketed by Allergan, Epic Pharma Llc, Aspen Global Inc, and Eugia Pharma. and is included in four NDAs.
The generic ingredient in HYDROXYPROGESTERONE CAPROATE is hydroxyprogesterone caproate. There are twelve drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydroxyprogesterone caproate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROXYPROGESTERONE CAPROATE?
- What are the global sales for HYDROXYPROGESTERONE CAPROATE?
- What is Average Wholesale Price for HYDROXYPROGESTERONE CAPROATE?
Summary for HYDROXYPROGESTERONE CAPROATE
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 30 |
| Patent Applications: | 6,047 |
| Drug Prices: | Drug price information for HYDROXYPROGESTERONE CAPROATE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for HYDROXYPROGESTERONE CAPROATE |
| What excipients (inactive ingredients) are in HYDROXYPROGESTERONE CAPROATE? | HYDROXYPROGESTERONE CAPROATE excipients list |
| DailyMed Link: | HYDROXYPROGESTERONE CAPROATE at DailyMed |
Recent Clinical Trials for HYDROXYPROGESTERONE CAPROATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bezmialem Vakif University | N/A |
| Assiut University | Phase 4 |
| Aswan University Hospital | N/A |
Pharmacology for HYDROXYPROGESTERONE CAPROATE
| Drug Class | Progestin |
Anatomical Therapeutic Chemical (ATC) Classes for HYDROXYPROGESTERONE CAPROATE
Paragraph IV (Patent) Challenges for HYDROXYPROGESTERONE CAPROATE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| MAKENA (AUTOINJECTOR) | Injection (Auto- injector) | hydroxyprogesterone caproate | 275 mg/1.1 mL | 021945 | 1 | 2020-09-28 |
US Patents and Regulatory Information for HYDROXYPROGESTERONE CAPROATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | HYDROXYPROGESTERONE CAPROATE | hydroxyprogesterone caproate | INJECTABLE;INJECTION | 017439-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Aspen Global Inc | HYDROXYPROGESTERONE CAPROATE | hydroxyprogesterone caproate | SOLUTION;INTRAMUSCULAR | 200271-001 | Aug 24, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Allergan | HYDROXYPROGESTERONE CAPROATE | hydroxyprogesterone caproate | INJECTABLE;INJECTION | 017439-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
